4/15
05:08 pm
annx
Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing [Yahoo! Finance]
Low
Report
Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing [Yahoo! Finance]
4/8
04:05 pm
annx
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference
4/1
07:27 am
annx
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Medium
Report
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
3/30
04:01 pm
annx
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
High
Report
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
3/20
08:26 am
annx
Annexon (ANNX) had its "buy" rating reaffirmed by Chardan Capital. They now have a $16.00 price target on the stock.
Medium
Report
Annexon (ANNX) had its "buy" rating reaffirmed by Chardan Capital. They now have a $16.00 price target on the stock.
3/18
10:16 pm
annx
Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4 [Yahoo! Finance]
Low
Report
Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4 [Yahoo! Finance]
3/16
04:05 pm
annx
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
3/4
06:06 am
annx
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference [Yahoo! Finance]
Medium
Report
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference [Yahoo! Finance]
2/24
08:00 am
annx
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
Low
Report
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
2/17
08:21 am
annx
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy [Yahoo! Finance]
Low
Report
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy [Yahoo! Finance]
2/17
08:00 am
annx
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
Low
Report
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
1/24
02:16 am
annx
Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases [Seeking Alpha]
Low
Report
Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases [Seeking Alpha]
1/23
05:05 am
annx
Annexon (NASDAQ:ANNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Annexon (NASDAQ:ANNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/18
10:21 am
annx
Assessing Annexon (ANNX) Valuation After EMA Filing For Tanruprubart In Guillain Barre Syndrome [Yahoo! Finance]
Low
Report
Assessing Annexon (ANNX) Valuation After EMA Filing For Tanruprubart In Guillain Barre Syndrome [Yahoo! Finance]
1/16
05:05 pm
annx
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)